PackGene Biotech
PrivateLast Round
Series C
Extension
Dec 1, 2023
Total Funding Raised
$59.29M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PackGene Biotech operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Series C Extension round in December 2023.
PackGene Biotech is a biotechnology company that provides comprehensive AAV vector, mRNA, plasmid DNA, and lentiviral vector solutions for early-stage drug discovery, preclinical development, and clinical trials.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PackGene Biotech Comparables
Compare PackGene Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VectorBuilder | 88% | |
| Andelyn Biosciences | 86% | |
| ReiThera | 82% |
For institutional investors. Book with your work email.
PackGene Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Dec 1, 2023 | ||||
| Series C | Apr 18, 2023 | ||||
| VC Round | Mar 1, 2021 | ||||
| Series B Extension | Oct 26, 2020 | ||||
| Series B | Aug 12, 2020 | ||||
Series A | Feb 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PackGene Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cathay Capital | VC Round, Series B Extension, Series B |
| 招银国际金融有限公司 | VC Round |
| Kaitai Capital | VC Round |
| Guangzhou Industrial Investment Fund Management | VC Round |
| Guangzhou Emerging Industry Development Fund Management Co., Ltd. | Series C |
| Guangzhou Development District Industry Fund Investment Group | Series C |
| SDIC Merchant | Series C Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 84% MoM, reaching 17.2K.
- Jul 1, 2026
Serves over 1,000 biopharma companies and research institutions in 30+ countries.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- expands_facilitiesSep 12, 2026
PackGene Biotech, Inc. expands its physical-facility footprint by opening a CDMO facility in the United States in Dec '24.
- receives_awardSep 12, 2026
At the 2026 Frost & Sullivan Global Growth, Innovation and Leadership Summit in China on Aug 4th '26, Frost & Sullivan presents the GLOBAL GENE THERAPY CRDMO TECHNOLOGY INNOVATION LEADERSHIP AWARD to PackGene Biotech, Inc. based on its research, analysis, and evaluation of the global Gene Therapy CRDMO industry enabling sector.
- receives_awardSep 12, 2026
Frost & Sullivan presents the global Gene Therapy crdmo technology Innovation Leadership Award to PackGene Biotech, Inc. at the 2026 Frost & Sullivan Global Growth, Innovation and Leadership Summit in China on Aug 4th '26, based on industry research, analysis, and evaluation.
- recognized_asSep 12, 2026
Frost & Sullivan recognizes PackGene Biotech, Inc. with the Global Gene Therapy CRDMO Technology Innovation Leadership Award at the 2026 Global Growth, Innovation and Leadership Summit in China on Aug 4th '26, following research and evaluation of the global Gene Therapy CRDMO industry enabling sector.
For institutional investors. Book with your work email.
PackGene Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PackGene Biotech's valuation, stock price, and market status.
Is PackGene Biotech a public or private company?
PackGene Biotech is a private company.
What is the current stock price of PackGene Biotech?
PackGene Biotech is a private company, so its shares have no public market price. Caplight tracks PackGene Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PackGene Biotech worth (valuation)?
Valuation information for PackGene Biotech is not publicly available.
Can I buy PackGene Biotech stock?
PackGene Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PackGene Biotech's last funding round?
PackGene Biotech's most recent funding round was Series C Extension on December 1, 2023.
Who are the main investors in PackGene Biotech?
Key investors in PackGene Biotech include Cathay Capital, 招银国际金融有限公司, Kaitai Capital, SDIC Merchant, HongShan Capital Group (HSG).
Will PackGene Biotech IPO soon?
No public IPO plans have been announced for PackGene Biotech.
How can I track PackGene Biotech secondary market activity?
Caplight tracks bids, offers, and trades in PackGene Biotech's shares on secondary markets.